sovateltide
Peptideexperimental
Clinical trial activity
10 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
8
Phase 3
2
Phase 4
1
Earliest trial started Jan 1, 2008 (NCT00613691)
Timeline
Indications
Approved for
Studied for
- Acute Febrile Encephalopathy · Phase 2
- Alzheimer Disease · Phase 2
- Biliary Tract Neoplasms · Phase 2
- Brain Ischemia · Phase 4
- Carcinoma · Phase 1
- Carcinoma, Non-Small-Cell Lung · Phase 2
- Cerebral Infarction · Phase 3
- Dementia · Phase 2
- Hypoxia-Ischemia, Brain · Phase 2
- Ischemic Stroke · Phase 3
- Neonatology · Phase 2
- Spinal Cord Injuries · Phase 2
- Stroke · Phase 3
Mechanism of action
- Endothelin-1Supplementation
EDN1 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- endothelin-1 (8-21), succinyl-(glu(9),ala(11,15))-
- irl 1620
- irl-1620
- l-tryptophan, n-(3-carboxy-1-oxopropyl)-l-alpha-aspartyl-l-alpha-glutamyl-l-alpha-glutamyl-l-alanyl-l-valyl-l-tyrosyl-l-phenylalanyl-l-alanyl-l-histidyl-l-leucyl-l-alpha-aspartyl-l-isoleucyl-l-isoleucyl-fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone, hemihydrate
- spi-1620
- spi-1620
- spi-1620
- succinyl-(glu(9),ala(11,15))-endothelin-1 (8-21)
- succinyl-(glutamyl(9)-alanyl(11,15))-endothelin-1 (8-21)
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05955326 | Phase 4 | Nov 30, 2023 | Pharmazz, Inc. |
| NCT05691244 | Phase 3 | Nov 30, 2023 | Pharmazz, Inc. |
| NCT05514340 | Phase 2 | Oct 31, 2022 | Pharmazz, Inc. |
| NCT04047563 | Phase 3 | Aug 31, 2019 | Pharmazz, Inc. |
| NCT04054414 | Phase 2 | Jan 10, 2019 | Pharmazz, Inc. |
| NCT04052737 | Phase 2 | Mar 23, 2018 | Pharmazz, Inc. |
| NCT04046484 | Phase 2 | Jan 19, 2018 | Pharmazz, Inc. |
| NCT01741155 | Phase 2 | May 1, 2013 | Spectrum Pharmaceuticals |
| NCT01773785 | Phase 2 | Apr 1, 2013 | Spectrum Pharmaceuticals |
| NCT00613691 | Phase 1 | Jan 1, 2008 | Spectrum Pharmaceuticals |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pharmazz, Inc. | For profit | 7 | 7 | 3 | 2018 |
| Spectrum Pharmaceuticals | For profit | 3 | 3 | 2 | 2008 |
2 organizations
Page 1 / 1